119 related articles for article (PubMed ID: 15603546)
21. Expression and purification of the cancer antigen SSX2: a potential cancer vaccine.
Huang CJ; Chen RH; Vannelli T; Lee F; Ritter E; Ritter G; Old LJ; Batt CA
Protein Expr Purif; 2007 Dec; 56(2):212-9. PubMed ID: 17931884
[TBL] [Abstract][Full Text] [Related]
22. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.
Odunsi K; Jungbluth AA; Stockert E; Qian F; Gnjatic S; Tammela J; Intengan M; Beck A; Keitz B; Santiago D; Williamson B; Scanlan MJ; Ritter G; Chen YT; Driscoll D; Sood A; Lele S; Old LJ
Cancer Res; 2003 Sep; 63(18):6076-83. PubMed ID: 14522938
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
24. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.
Tammela J; Jungbluth AA; Qian F; Santiago D; Scanlan MJ; Keitz B; Driscoll D; Rodabaugh K; Lele S; Old LJ; Odunsi K
Cancer Immun; 2004 Oct; 4():10. PubMed ID: 15487888
[TBL] [Abstract][Full Text] [Related]
25. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
27. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.
Jäger D; Unkelbach M; Frei C; Bert F; Scanlan MJ; Jäger E; Old LJ; Chen YT; Knuth A
Cancer Immun; 2002 Jun; 2():5. PubMed ID: 12747750
[TBL] [Abstract][Full Text] [Related]
28. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
[TBL] [Abstract][Full Text] [Related]
29. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.
Yang K; Lui WO; Xie Y; Zhang A; Skytting B; Mandahl N; Larsson C; Larsson O
Oncogene; 2002 Jun; 21(26):4181-90. PubMed ID: 12037676
[TBL] [Abstract][Full Text] [Related]
30. The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP.
de Bruijn DR; dos Santos NR; Kater-Baats E; Thijssen J; van den Berk L; Stap J; Balemans M; Schepens M; Merkx G; van Kessel AG
Genes Chromosomes Cancer; 2002 Jul; 34(3):285-98. PubMed ID: 12007189
[TBL] [Abstract][Full Text] [Related]
31. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
32. SSX2-4 expression in early-stage non-small cell lung cancer.
Greve KB; Pøhl M; Olsen KE; Nielsen O; Ditzel HJ; Gjerstorff MF
Tissue Antigens; 2014 May; 83(5):344-9. PubMed ID: 24645645
[TBL] [Abstract][Full Text] [Related]
33. [The expression of 11 cancer/testis (CT) antigen genes in esophageal carcinoma].
Liang Z; Sun ZY; Yuan YH; Han Y; Wang Y; Gu J; Zhang LJ
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):534-7. PubMed ID: 16438850
[TBL] [Abstract][Full Text] [Related]
34. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
35. [Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].
Chen HS; Qin LL; Cong X; Wang Y; Fei R; Jiang D; Cao J; Su JJ; Wei L; Chen WF; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):145-8. PubMed ID: 12681059
[TBL] [Abstract][Full Text] [Related]
36. Expression of cancer-testis antigen in multiple myeloma.
He L; Ji JN; Liu SQ; Xue E; Liang Q; Ma Z
J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):181-185. PubMed ID: 24710929
[TBL] [Abstract][Full Text] [Related]
37. [Expression of SSX2 gene in human urologic neoplasms].
Du P; Yu LZ; Ma M; Geng L; Wang XS; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):379-81. PubMed ID: 15854347
[TBL] [Abstract][Full Text] [Related]
38. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
[TBL] [Abstract][Full Text] [Related]
39. A novel type of SYT/SSX fusion: methodological and biological implications.
Törnkvist M; Brodin B; Bartolazzi A; Larsson O
Mod Pathol; 2002 Jun; 15(6):679-85. PubMed ID: 12065783
[TBL] [Abstract][Full Text] [Related]
40. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR.
Das H; Koizumi T; Sugimoto T; Chakraborty S; Ichimura T; Hasegawa K; Nishimura R
Br J Cancer; 2000 May; 82(10):1682-8. PubMed ID: 10817504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
